Study Designed to Evaluate the Effect of CimetrA in Patients Diagnosed With COVID-19

NCT05037162 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
240
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

MGC Pharmaceuticals d.o.o